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Given the evolutionary relationship of the mitochon-
drial IMS to the bacterial periplasm, one cannot help
but draw parallels between the function of mitochon-
drial Erv1 and its bacterial counterpart dsbB, which is
functionally related to Erv2 of the eukaryotic endoplas-
mic reticulum. Erv1 oxidizes Mia40, and dsbB oxidizes
dsbA. These proteins in turn oxidize translocated sub-
strates. The new findings may relieve some of the initial
skeptisicm about the idea of oxidative protein folding
in mitochondria. This idea is, after all, counterintuitive
given the fact that the mitochondrial IMS is thought to
be in equilibrium with the cell cytosol, with free ex-
change of metabolites between the IMS and cytosol via
porin channels. However, defining specific redox part-
ners, such as Erv1, Mia40, and possibly Hot13, should
help to elucidate further the mechanisms involved in
oxidative protein folding. We have identified just the tip
of the iceberg of an unexpected mechanism that may
be crucial for the physiological response of cells to re-
dox conditions.
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Stem Cell Grand SLAM
Stem cells in both embryonic and adult tissues are
defined by their unique ability to balance self-renewal
and differentiation such that mature cells necessary
for tissue function can be generated and replaced
without depletion of the stem cell pool. In this issue
of Cell, Kiel et al. (2005) report a major step forward
for studying the mechanisms and regulation of such
stem cell fate decisions in the blood-forming (hemato-
poietic) system by providing a simple and broadly ap-
plicable method to isolate these cells and to visualize
them in their normal environment.
Using large-scale gene expression profiling, Kiel et al.
report in this issue the identification of a family of cell-
surface receptors that phenotypically distinguishes
hematopoietic stem and progenitor cells that have dis-
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968tinct self-renewal and differentiation capacities. In a p
hscreen designed to reveal genes selectively expressed
by immature blood precursor cells, the authors com- s
apared the gene expression profiles of long-term recon-
stituting-hematopoietic stem cells (LT-HSC) and multipo- v
btent progenitors (MPP) with that of total bone marrow
cells. Both LT-HSC and MPP give rise to all lineages of c
pblood cell types. However, whereas LT-HSC possess
the capacity for extensive self-renewal, as demon- v
astrated by their ability to maintain lifelong production
of blood cells, MPP provide only transient contributions H
bto hematopoietic lineages. The use of these two highly
enriched populations of closely related precursor cells o
b(LT-HSC and MPP), whose purity was ensured by multi-
ple markers and confirmed by functional in vivo recon- a
Sstitution assays, was one key to the success of this
study. Applying stringent criteria to their data in order H
Hto select differentially expressed genes among these
populations, the authors identified a set of only 27 e
pgenes showing higher expression in LT-HSC over both
MPP and total bone marrow cells. One of these mole- g
tcules—signaling lymphocyte activation molecule, or
SLAM— attracted the authors’ attention because its m
selective expression on the cell surface of LT-HSC po-
tentially could provide a new and improved strategy for a
estem cell isolation.
Further investigation revealed that SLAM (also known S
tas CD150) is present on the surface of a minority of
CD45+ (hematopoietic) bone marrow cells but marks a H
hsubstantial fraction of the highly enriched HSC popula-
tion used in the original transcriptional profiling analy- t
osis. In transplantation assays, CD150-positive, but not
CD150-negative, bone marrow cells provided repro- S
pducible and robust long-term, multilineage reconstitu-
tion of blood cells in irradiated recipient mice, fulfilling c
wthe “gold-standard” test for HSC function. Remarkably,
analysis of additional members of the SLAM family c
d(CD244 and CD48) demonstrated strikingly selective
expression of different SLAM receptors by LT-HSC, c
tMPP, or oligolineage-restricted progenitor cells (see
Figure 1). This “SLAM code” could be used to predict f
kthe “primitiveness” of hematopoietic precursor cells. In
addition, this code greatly simplified the prospective t
disolation of LT-HSC from different strains of adult mice
as well as from sites of extramedullary hematopoiesis s
rin animals treated with hematopoietic growth factors.
Because traditional strategies for LT-HSC enrichment p
Ahave relied on complex combinations of numerous
markers, which often are expressed in a strain-specific r
tand activation-dependent manner, the Kiel et al. study
provides a significant advance by establishing and vali- w
fdating a simple and broadly applicable method for the
identification and isolation of highly purified popula-
ntions of mouse LT-HSC.
Previous work has suggested that HSC self-renewal l
tand differentiation is likely to be regulated both by stem
cell-intrinsic determinants and by specific interactions o
bwith surrounding cells that constitute a unique stem cell
“niche.” This niche is thought to provide factors essen- e
itial for stem cell maintenance and to translate external
signals that influence stem cell developmental deci- s
gsions. However, direct visualization of these specialized
stem cell microenvironments has been, until recently, t
Hproblematic. Recognizing that the highly selective ex-ression of SLAM family members among immature
ematopoietic cells might provide a simple method for
pecifically identifying stem cells in tissue sections, the
uthors took further advantage of these markers to in-
estigate the anatomical localization of LT-HSC in the
one marrow and spleen. Significantly, several crucial
ontrol experiments confirmed the reliability of this ap-
roach for detecting LT-HSC in situ. These analyses re-
ealed that, consistent with previous studies (Calvi et
l., 2003; Nilsson et al., 2001; Zhang et al., 2003), LT-
SC are enriched in the trabecular region of normal
one marrow and in some cases are localized to the
steoblast-containing endosteal region (adjacent to the
one). In addition, LT-HSC frequently were seen associ-
ted with endothelial cells lining the marrow sinusoids.
imilarly, in animals treated with agents that induce
SC migration and hematopoiesis in the spleen, LT-
SC were often found in direct contact with sinusoidal
ndothelial cells within the splenic parafollicular red
ulp. Together, these findings extend previous investi-
ations of HSC niches within bone marrow and provide
he first description of a niche for HSC outside the
arrow.
The Kiel et al. study provides several important insights
nd raises critical issues relevant to understanding and
xploiting HSC function. First, given the broad utility of
LAM receptors for identifying LT-HSC in adult mice,
his strategy may similarly simplify the isolation of LT-
SC from embryonic and fetal tissues, which thus far
as been complicated by developmental variations in
he anatomical location and cell-surface marker profile
f these cells. In addition, if conserved across species,
LAM expression by human bone marrow or mobilized
eripheral blood cells harvested for transplantation
ould provide a superior predictor of graft success,
hich currently relies on enumeration of CD34-positive
ells representing a mixture of primitive HSC and more
ifferentiated progenitor cells. The normal physiologi-
al role (if any) of SLAM receptor expression by primi-
ive hematopoietic cells remains to be determined. This
amily of cell-surface proteins consists of at least nine
nown immunoglobulin-like receptors, closely related
o the CD2 gene family, which have been studied pre-
ominantly for their role in modulating immune re-
ponses. These proteins act as adhesion and signaling
eceptors and were not previously known to be ex-
ressed by immature blood cells (Engel et al., 2003).
s the authors’ initial analyses of mice lacking CD150
evealed no changes in LT-HSC frequency or reconstitu-
ion capacity in these animals, it appears that SLAM,
hile useful as a stem cell marker, may not be essential
or HSC function.
The association of SLAM-expressing LT-HSC with si-
usoidal endothelium in at least two distinct anatomical
ocations is intriguing. Several studies have suggested
hat HSC niches are likely to include at least a subset
f osteoblasts that are particularly enriched within tra-
ecular bone (Arai et al., 2004; Calvi et al., 2003; Zhang
t al., 2003). The functional importance of osteoblasts
n regulating HSC number has been demonstrated by
tudies showing that mutant mice with expanded re-
ions of trabecular bone and increased numbers of os-
eoblasts exhibit concomitant increases in bone marrow
SC (Calvi et al., 2003; Zhang et al., 2003), that genetic
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969Figure 1. Differential Expression of the SLAM Family Receptors,
CD150, CD48, and CD244, Marks Hematopoietic Precursor Cells at
Different Stages of Differentiation
(A) Self-renewal potential decreases as LT-HSC differentiate, giving
rise to MPP and to a pool of oligolineage-restricted progenitor
(OP) cells.
(B) In normal mice and in animals treated with hematopoietic
growth factors, LT-HSC (green) circulate in the bloodstream and
may be supported by sinusoidal (black) or osteoblastic (gray)
niches in distinct tissues. LT-HSC may associate with liver sinus-
oids, but this has not yet been demonstrated.ablation of osteoblasts leads to marrow failure (Visnjic
et al., 2004), and that factors elaborated by osteoblasts
may regulate HSC number (Nilsson et al., 2005; Stier
et al., 2005). Yet other lines of evidence suggest that
endothelial cells could provide a niche for HSC. Hemato-
poietic and endothelial cells emerge concurrently dur-
ing development, and HSC closely associate with en-
dothelium in the extraembryonic yolk sac and in the
HSC-enriched AGM (aorta/gonad/mesonephros) region
of the embryo proper. In addition, explanted endothelial
cells can help to maintain HSC in culture (Li et al.,
2004). The studies reported by Kiel et al. help to integ-
rate these observations, supporting the notion that
HSC may interact with either osteoblasts or endothelial
cells in different tissues or under different conditions.
Furthermore, they implicate specialized sinusoidal en-
dothelium as a newly defined niche for LT-HSC.
Only three tissues within the body are characterized
by the presence of sinusoidal endothelium—the liver,
spleen, and bone marrow—and each of these tissues
supports hematopoietic cell development during fetal
and/or adult life. Furthermore, both the liver and spleen
may become sites of extramedullary hematopoiesis in
certain pathological conditions. Sinusoids are low-
pressure vascular channels lined with large, irregular,
nonoverlapping endothelial cells that typically contain
no junctional complexes and an incomplete basement
membrane. Sinusoidal endothelium is highly fenes-
trated, allowing virtually unimpeded flow of molecules
and mediators present in the sinusoidal plasma acrossits thin walls. Consequently, cells associated with si-
nusoids are effectively bathed in circulating factors.
Thus, association of HSC with marrow, splenic, and
perhaps liver sinusoids could be important for main-
taining homeostatic blood cell production and enabling
rapid and robust responses to hematological stress by
providing HSC with a constant sampling of the body’s
hematological state via blood-borne factors in the si-
nusoidal circulation. In addition, given that blood cells
typically re-enter the circulation through the sinusoids,
the localization of HSC to regions close to these ves-
sels may help to explain the apparent constitutive, low-
level circulation of these cells in normal animals (Wright
et al., 2001), as well as observations that release of HSC
into the bloodstream can substantially increase within
minutes of treatment with certain cytokines and/or ad-
hesion/chemokine receptor antagonists.
Several important questions still remain to be an-
swered. For example, are sinusoidal and endosteal
niches functionally identical? Are they coordinately reg-
ulated? Do LT-HSC move freely between them? Some
studies have suggested that sinusoidal endothelium
may promote the proliferation and differentiation of im-
mature progenitor cells, while association with osteo-
blasts may play a more prominent role in maintaining
HSC quiescence (Heissig et al., 2002; Arai et al., 2004).
The ability to directly image both dividing and nondivid-
ing SLAM-positive LT-HSC in the bone marrow should
allow clarification of this issue and furthermore should
enable resolution of long-standing questions regarding
the symmetry of LT-HSC division in vivo, such as
whether, as in the Drosophila gonad, niche cell-deter-
mined orientation of the mitotic spindle sets up asym-
metry in LT-HSC division allowing one daughter stem
cell to be displaced from the niche to begin the process
of differentiation (Yamashita et al., 2003). For these and
other studies, the availability of a simple and direct
method for purifying and visualizing LT-HSC, as estab-
lished by the work of Kiel et al., clearly makes possible
a new level of precision for defining cellular and molec-
ular regulators of stem cell fate decisions.
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